Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

142 countries to get 237 mln vaccines doses from COVAX by end May - WHO

Published 02/03/2021, 13:30
Updated 02/03/2021, 13:36
© Reuters

GENEVA, March 2 (Reuters) - Some 237 million doses of
AstraZeneca (NASDAQ:AZN)'s AZN.L COVID-19 vaccine are expected to be
delivered to 142 countries by the end of May through the COVAX
facility, the head of the World Health Organization (WHO) said
on Tuesday.
Tedros Adhanom Ghebreyesus, WHO director-general, told a
news conference that vaccine deliveries were planned on Tuesday
to Angola, Cambodia, the Democratic Republic of Congo and
Nigeria.
Ghana's president Nana Akufo-Addo said his West African
country, which has begun its innoculation campaign with COVAX
doses, aimed to vaccinate 20 million people by the end of 2021.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.